Aortic geometry and long-term outcome in patients with a repaired coarctation.


Journal

Open heart
ISSN: 2053-3624
Titre abrégé: Open Heart
Pays: England
ID NLM: 101631219

Informations de publication

Date de publication:
28 May 2024
Historique:
received: 09 04 2024
accepted: 15 05 2024
medline: 29 5 2024
pubmed: 29 5 2024
entrez: 28 5 2024
Statut: epublish

Résumé

This study aims to compare aortic morphology between repaired coarctation patients and controls, and to identify aortic morphological risk factors for hypertension and cardiovascular events (CVEs) in coarctation patients. Repaired coarctation patients with computed tomography angiography (CTA) or magnetic resonance angiography (MRA) were included, followed-up and compared with sex-matched and age-matched controls. Three-dimensional aortic shape was reconstructed using patients' CTA or MRA, or four-dimensional flow cardiovascular magnetic resonance in controls, and advanced geometrical characteristics were calculated and visualised using statistical shape modelling. In patients, we examined the association of geometrical characteristics with (1) baseline hypertension, using multivariable logistic regression; and (2) cardiovascular events (CVE, composite of aortic complications, coronary artery disease, ventricular arrhythmias, heart failure hospitalisation, stroke, transient ischaemic attacks and cardiovascular death), using multivariable Cox regression. The least absolute shrinkage and selection operator (LASSO) method selected the most informative multivariable model. Sixty-five repaired coarctation patients (23 years (IQR 19-38)) were included, of which 44 (68%) patients were hypertensive at baseline. After a median follow-up of 8.7 years (IQR 4.8-15.4), 27 CVEs occurred in 20 patients. Aortic arch dimensions were smaller in patients compared with controls (diameter p<0.001, wall surface area p=0.026, volume p=0.007). Patients had more aortic arch torsion (p<0.001) and a higher curvature (p<0.001). No geometrical characteristics were associated with hypertension. LASSO selected left ventricular mass, male sex, tortuosity and age for the multivariable model. Left ventricular mass (p=0.014) was independently associated with CVE, and aortic tortuosity showed a trend towards significance (p=0.070). Repaired coarctation patients have a smaller aortic arch and a more tortuous course of the aorta compared with controls. Besides left ventricular mass index, geometrical features might be of importance in long-term risk assessment in coarctation patients.

Identifiants

pubmed: 38806222
pii: openhrt-2024-002642
doi: 10.1136/openhrt-2024-002642
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Savine C S Minderhoud (SCS)

Department of Cardiology, Erasmus Medical Center, Rotterdam, The Netherlands.
Department of Radiology, Erasmus Medical Center, Rotterdam, The Netherlands.

Rick van Montfoort (R)

Department of Cardiology, Erasmus Medical Center, Rotterdam, The Netherlands.

Timion A Meijs (TA)

Department of Cardiology, University Medical Centre Utrecht, Utrecht, The Netherlands.

Suze-Anne Korteland (SA)

Department of Cardiology, Erasmus Medical Center, Rotterdam, The Netherlands.

Jan L Bruse (JL)

Vicomtech Foundation, Basque Research and Technology Alliance, Donostia-San Sebastián, Spain.

Isabella Kardys (I)

Department of Cardiology, Erasmus Medical Center, Rotterdam, The Netherlands.

Jolanda J Wentzel (JJ)

Department of Cardiology, Erasmus Medical Center, Rotterdam, The Netherlands.

Michiel Voskuil (M)

Department of Cardiology, University Medical Centre Utrecht, Utrecht, The Netherlands.

Alexander Hirsch (A)

Department of Cardiology, Erasmus Medical Center, Rotterdam, The Netherlands.
Department of Radiology, Erasmus Medical Center, Rotterdam, The Netherlands.

Jolien W Roos-Hesselink (JW)

Department of Cardiology, Erasmus Medical Center, Rotterdam, The Netherlands.

Annemien E van den Bosch (AE)

Department of Cardiology, Erasmus Medical Center, Rotterdam, The Netherlands a.e.vandenbosch@erasmusmc.nl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH